Viewing nowLosartan 50 mg (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

MFDS item code 200401773 · Approved 2004.09.21 · Insurance code 644300930
Treatment of hypertension and nephropathy in patients with type 2 diabetes and hypertension
This medication is used as a treatment for patients with hypertension. It is particularly helpful in preventing and treating kidney disease in patients with type 2 diabetes who have hypertension. Therefore, it is effective in preventing complications related to the management of hypertension.
This drug may be taken with or without food, but it is recommended to take it at the same time each day. 1. Hypertension The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this drug alone, it may be administered in combination with another antihypertensive drug (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this drug once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered concomitantly with insulin and commonly used hypoglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations No initial dose adjustment is necessary in elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for Use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years or older, weighing 20 kg or more but less than 50 kg, who are able to swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50 mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Not recommended for children younger than 6 years, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This medication can cause serious damage to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Women who are likely to become pregnant should refrain from taking this medication. Patients with severely impaired liver function or hereditary lactose intolerance should not use this medication. Elderly patients, those with weak kidney function, or patients with high serum potassium levels should use this medication with caution and require regular testing. This medication lowers blood pressure, so caution should be taken for symptoms of hypotension when initially starting the medication or increasing the dose. Potassium supplements or other medications containing potassium should not be taken concurrently as it may increase potassium levels in the blood. Dizziness or drowsiness may occur during treatment, so caution should be exercised when driving or operating hazardous machinery. This medication can affect liver and kidney function, so if any unusual symptoms arise, consult a physician immediately. Regular monitoring of blood pressure and blood tests is important to check health status during treatment. In case of overdose, symptoms such as hypotension and bradycardia may occur, and immediate medical attention should be sought if symptoms are severe.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture and should be stored in a tightly sealed container. It is also recommended to keep it in a cool, dry place at a temperature between 15 to 30 degrees Celsius.
White oval film-coated tablets
Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle, PTP (for export) - 30 tablets/box [10 tablets/PTP * 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.